Albumin Utilization in Adult Cardiac Surgical Patients: Retrospective

Condition(s) studied

Study summary

All heart surgery patients universally require hydration, which is given through a vein in the arm, but practices for treating patients are not universal. There are disagreements about whether crystalloids should be used alone or in combination with albumin. This question has important implications because albumin is an expensive blood product in relatively limited supply, and 20% of its use is by heart surgery patients. The goal of this study is to learn more about how crystalloids and albumin are used during heart surgery, as well as, key patient outcomes.

Eligibility

Primary outcome measure(s)

• Albumin — On CPB, in the operating room but not during CPB, in the ICU, on the ward to post operative day 28.
  Type, dose and timing of administration, the setting in which it was ordered, indication for use, and the type of provider responsible for the patient at administration (surgeon, anesthesiologist, intensivist, nurse practitioner).
• Crystalloid, volume dose and type administered — On CPB, in the operating room but not during CPB, in the ICU, on the ward to post operative day 28.
  Type and volume of crystalloid given (Normal saline, Ringer's Lactate, Plasmalyte-148, and others), as well as the setting of administration will be recorded.

Trial sites (10)

More University Health Network, Toronto trials in Canada